119 related articles for article (PubMed ID: 11298406)
21. Muscular dystrophy campaign: putting some financial muscle behind finding a cure.
Pohlschmidt M
Stem Cells Transl Med; 2012 Apr; 1(4):261-2. PubMed ID: 23197804
[TBL] [Abstract][Full Text] [Related]
22. Autism Speaks: the United States pays up.
Nature; 2007 Aug; 448(7154):628-9. PubMed ID: 17687286
[No Abstract] [Full Text] [Related]
23. Kavli invests in institutes.
Hand E
Nature; 2008 Oct; 455(7214):713. PubMed ID: 18843322
[No Abstract] [Full Text] [Related]
24. Partnerships between philanthropy, government and industry are needed to advance drug discovery for neurodegenerative diseases.
Refolo LM; Fillit HM
Curr Alzheimer Res; 2006 Jul; 3(3):175-6. PubMed ID: 16842090
[No Abstract] [Full Text] [Related]
25. Crowd-funding: Cash on demand.
Kaplan K
Nature; 2013 May; 497(7447):147-9. PubMed ID: 23646365
[No Abstract] [Full Text] [Related]
26. A firm response to AIDS.
Nature; 2006 Oct; 443(7113):738-9. PubMed ID: 17051178
[No Abstract] [Full Text] [Related]
27. [Ethics, health and money. Philanthropic big companies scrutinized in USA].
Jeppsson A
Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1885. PubMed ID: 22111224
[No Abstract] [Full Text] [Related]
28. The future of funding for MS research.
Hanson T
Ann N Y Acad Sci; 1984; 436():472-4. PubMed ID: 6598025
[No Abstract] [Full Text] [Related]
29. [Scaremongering Cancer Fund raising propaganda is unethical].
Finer D; Sachs L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2783-4; discussion 2784. PubMed ID: 16245554
[No Abstract] [Full Text] [Related]
30. Alternative funding: Sponsor my science.
Ledford H
Nature; 2012 Jan; 481(7381):254-5. PubMed ID: 22258588
[No Abstract] [Full Text] [Related]
31. Embryonic stem cell research controversy: focus on the private sector and international sphere.
Kim S
Hastings Womens Law J; 2003; 14(1):89-108. PubMed ID: 16032810
[No Abstract] [Full Text] [Related]
32. Keeping the U.S. a world leader in science.
Gentile JM
Science; 2007 Jul; 317(5835):194. PubMed ID: 17626863
[No Abstract] [Full Text] [Related]
33. Stem cell losses and gains in the US.
DeFrancesco L; Cimons M
Nat Med; 2001 Oct; 7(10):1076. PubMed ID: 11590410
[No Abstract] [Full Text] [Related]
34. Budget policy. U.S. science adviser tells researchers to look elsewhere.
Mervis J
Science; 2007 May; 316(5826):817-8. PubMed ID: 17495147
[No Abstract] [Full Text] [Related]
35. Starting small and early for research funding.
Pressler JL; Kenner CA
Nurse Educ; 2009; 34(4):141-2. PubMed ID: 19574844
[TBL] [Abstract][Full Text] [Related]
36. Science and politics: a fatal mix?
Joachim C
Nat Mater; 2004 Jul; 3(7):416. PubMed ID: 15229483
[No Abstract] [Full Text] [Related]
37. Japanese council urges reform of funding system.
Triendl R
Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
[No Abstract] [Full Text] [Related]
38. Rising to the challenge.
Kirby RS; Fitzpatrick JM
BJU Int; 2012 Dec; 110(11):1576-7. PubMed ID: 22882322
[No Abstract] [Full Text] [Related]
39. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
40. Ten simple rules for getting grants.
Bourne PE; Chalupa LM
PLoS Comput Biol; 2006 Feb; 2(2):e12. PubMed ID: 16501664
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
